-
This, the final issue of our updating journal for medicines, includes articles on the Paediatric Regulation, Risk Management Plans, and guidance on the submission of Decentralised and Centralised Procedure applications.
-
This issue of our updating journal for medicines includes: compliance with new legal requirements for patient information leaflets; an update on Periodic Safety Update Reports (PSUR) applications; the Pharmacovigilance Service Desk providing a service to marketing authorisation (MA) holders; and the Regulatory Information Service.
-
This issue of our updating journal for medicines includes: best practice guidance on the processing of national marketing authorisations; compliance with the new legal requirements for patient information leaflets; and a request for notification of inspections performed in the UK by overseas Inspectorates.
-
This issue of our updating journal for medicines includes clarification of the fee applicable for product licence applications and variations which are electronic Common Technical Document (eCTD) compliant.
-
This issue of our updating journal for medicines includes articles on: the proposals for MHRA fees (implemented on 1 April 2007); when risk management plans are required; and guidance for notification of serious breaches of Good Clinical Practice (GCP) or the trial protocol.
-
This issue of our updating journal for medicines includes an article on disruptions to the supply of medicines and interpretation of the 'Sunset Clause', and information on requesting the MHRA to act as Reference Member State (RMS) in decentralised procedures.
-
This issue of our updating journal for medicines includes a reminder about our Regulatory Information Service and an article on the provision of scientific advice for risk management planning.
-
Special issue of MAIL with FAQs, defining a standard approach to sending submissions to the MHRA.
-
Special Mail 6 highlights our 'Drugs, Devices and Regulations' conference and exhibition to be held in London on 5-6 February 2007.
-
This issue of our updating journal for medicines includes articles on updated product information for neuroleptics and new requirements for patient information leaflets.